NEWLINK GENETICS (NLNK) Covered Calls

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians.

You can sell covered calls on NEWLINK GENETICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NLNK (prices last updated Tue 4:16 PM ET):

NEWLINK GENETICS (NLNK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
5.20 +0.08 5.04 5.48 599K - 0.2B
Covered Calls For NEWLINK GENETICS (NLNK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 5 0.30 5.18 -3.5% -51.1%
Jul 20 5 0.55 4.93 1.4% 8.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

NewLink Genetics Corp. is a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Its portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a wide range of oncology indications. The company's products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189 and IDO Pathway Inhibitors. NewLink Genetics was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.